The 4T Score Calculator assesses pretest probability of heparin-induced thrombocytopenia (HIT) using four validated clinical criteria. Stratify patients as low, intermediate, or high probability to guide anticoagulation decisions and laboratory testing.
0
1
0
1
The calculator for the 4T Score quantifies the clinical probability of heparin-induced thrombocytopenia (HIT) before laboratory confirmation is available. HIT is a potentially life-threatening immune-mediated reaction in which antibodies against platelet factor 4 (PF4)–heparin complexes cause paradoxical platelet activation, leading to thrombocytopenia and a prothrombotic state that can produce devastating arterial and venous thromboembolism despite — or because of — ongoing heparin therapy.
Each criterion is scored 0, 1, or 2 points, for a maximum total of 8. The four domains are:
Thrombocytopenia magnitude | Timing of platelet fall | Thrombosis or other sequelae | oTher causes of thrombocytopenia
The timing criterion is the most diagnostically specific: a platelet fall beginning 5–10 days after heparin initiation (or within 1 day in re-exposure) scores 2 points and strongly suggests HIT. Falls occurring outside this window are less specific. The bleeding & anticoagulation calculators category includes related tools for INR, platelet dosing, and hemorrhage risk scoring.
The 4T Score stratifies patients into three probability categories with markedly different management implications:
0–3 pts: Low probability (~5% HIT) | 4–5 pts: Intermediate (~14%) | 6–8 pts: High (~64%)
A low score (0–3) has a negative predictive value exceeding 99% — HIT can be safely excluded without laboratory testing, and heparin may be continued. An intermediate or high score mandates immediate heparin cessation, initiation of an alternative anticoagulant, and urgent laboratory confirmation with a functional assay (serotonin release assay) or immunoassay (anti-PF4/heparin ELISA). Do not wait for lab results before acting on a high clinical score.
Warfarin is absolutely contraindicated in acute HIT due to its inhibition of protein C, a natural anticoagulant. In the context of HIT's existing hypercoagulable state, warfarin-induced protein C depletion can trigger venous limb gangrene and skin necrosis. Alternative anticoagulants — argatroban, bivalirudin, fondaparinux, or direct oral anticoagulants — must be used until platelet counts recover above 150 × 10⁹/L before any transition to warfarin is considered. Use this online calculator alongside current institutional HIT protocols.
The 4T Score is a clinical decision support tool, not a diagnostic standard. Its primary limitation is moderate interrater variability — the timing and thrombocytopenia criteria require clinical judgment that differs between providers. Studies show κ values of 0.40–0.60 for the timing criterion. The score performs best when applied by experienced clinicians familiar with HIT. A low score is highly reliable for ruling out HIT; intermediate and high scores require laboratory confirmation before treatment decisions are finalized. The INR calculator and platelet calculator provide supplementary data for managing anticoagulation in these patients.
Four criteria are scored 0-2 points each: Thrombocytopenia (degree and nadir), Timing (onset relative to heparin), Thrombosis (new clots or sequelae), and oTher causes (alternative explanations). Total 0-3: Low probability (<5%, high NPV). Total 4-5: Intermediate (14%). Total 6-8: High probability (64%). The score guides whether to test for HIT antibodies and start alternative anticoagulation.
Low probability (0-3): HIT effectively ruled out; negative predictive value >99%. Continue heparin, investigate other causes. Intermediate (4-5): HIT possible; send antibody testing, consider stopping heparin and starting alternative anticoagulant. High (6-8): HIT likely; immediately stop heparin, start alternative anticoagulant (argatroban, bivalirudin, fondaparinux), send confirmatory testing.
Inputs
Results
Score 1. Platelet fall on day 2 with sepsis present. HIT very unlikely.
Inputs
Results
Score 8. Classic HIT presentation requiring immediate intervention.
Heparin-induced thrombocytopenia is an immune reaction where antibodies against platelet factor 4-heparin complexes cause platelet activation, thrombocytopenia, and paradoxical hypercoagulability leading to thrombosis.
HIT occurs in 0.5-5% of heparin-exposed patients, more commonly with unfractionated heparin than LMWH, and more in surgical than medical patients. Clinically significant HIT with thrombosis affects about 0.5-1%.
A 4T score of 0-3 has a negative predictive value exceeding 99% for HIT. This is the score's greatest clinical utility: reliably ruling out HIT and avoiding unnecessary treatment changes.
Immunoassays (ELISA for anti-PF4/heparin antibodies) are sensitive but less specific. Functional assays (serotonin release assay, heparin-induced platelet activation) are the gold standard but take longer and are less widely available.
Direct thrombin inhibitors (argatroban, bivalirudin) are the classic alternatives. Fondaparinux (factor Xa inhibitor) is increasingly used off-label. DOACs (rivaroxaban, apixaban) are used for transition after initial parenteral therapy.
Yes, but less frequently than unfractionated heparin. LMWH cross-reacts with HIT antibodies in approximately 90% of cases, so it must NOT be substituted when HIT is diagnosed on unfractionated heparin.
Suspect HIT when platelet count falls >30% from baseline 5-10 days after heparin start, when thrombosis occurs during heparin therapy, when there is unexplained heparin resistance, or with skin necrosis at injection sites.
Delayed HIT presents days to weeks after heparin cessation. Patients develop thrombocytopenia and/or thrombosis after discharge. Anti-PF4 antibodies persist and activate platelets even without ongoing heparin exposure.
No. If intermediate or high probability, start alternative anticoagulation immediately while awaiting lab confirmation. HIT thrombosis risk is highest in the first few days and can cause limb loss or death.
Warfarin must NOT be started during acute HIT. It depletes protein C faster than procoagulant factors, worsening hypercoagulability. Warfarin can be started only after platelet recovery (>150,000) while on alternative anticoagulation.
How helpful was this calculator?
5.0/5 (1 rating)
Oxygen Tank Duration Calculator
Oxygen & Ventilation Calculators
Oxygen Consumption Calculator
Oxygen & Ventilation Calculators
Dead Space Calculator (Bohr Equation)
Oxygen & Ventilation Calculators
Ventilator Settings Calculator
Oxygen & Ventilation Calculators
eGFR Calculator (CKD-EPI 2021)
Nephrology Calculators
Creatinine Clearance Calculator (Cockcroft-Gault)
Nephrology Calculators